Flatiron Health and the FDA Embark on Cancer Research Collaboration

May 25, 2016 at 12:00am

Flatiron Health and the U.S. Food and Drug Administration (FDA) have signed a research collaboration agreement to determine how real-world evidence derived from de-identified, HIPAA-compliant patient data captured outside of clinical trials can provide new insights into the safety and effectiveness of emerging anti-cancer therapies such as immunotherapeutic agents.

View Article

Back to Press